Tag: prostate

Study shows notable outcomes with cryoablation and prostate cancer

A less-invasive treatment technique called hemi-gland cryoablation (HGCryo)—destroying the areas of the prostate where cancers are located by freezing them—provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology, Official Journal of the American Urological Association (AUA). “Freedom from cancer, as documented by biopsy, was

New blood test for prostate cancer could help monitor patients

New blood test for prostate cancer could help monitor patients without invasive procedure and would reveal if they need urgent treatment Prostate cancer is most common among UK men with 50,000 diagnosed a year Study published in Journal of Clinical Investigation offers hope of a blood test At present the cancer is diagnosed through physical

Recruitment of miR-8080 by luteolin inhibits AR-V7 in castration-resistant prostate cancer

Prostate cancer is the most common noncutaneous malignancy in the United States and is responsible for many male deaths. The development of prostate carcinogenesis is initially androgen-dependent. However, the progression of castration-resistant prostate cancer (CRPC) following androgen deprivation therapy is a major clinical problem. Although enzalutamide and abiraterone have been approved for CRPC hormone therapy,

Study explores new tracer in prostate cancer hunt

A new study looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. A multi-center trial registry testing the use of a new imaging tracer—prostate specific membrane antigen (PSMA) – is

Revolutionising care for prostate cancer patients

An innovative new digital model of follow-up care for prostate cancer allows patients to see test results online as soon as they become available, after a report was published in BMC Cancer. Researchers from the University of Southampton, funded by the Movember Foundation and delivered in partnership with Prostate Cancer UK, trialled the True NTH

New insights into treatment targets for men with advanced prostate cancers

A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. Using comprehensive genomic profiling (CGP) to analyze thousands of tumor samples from men with advanced prostate cancers, the researchers identified that 57

Prostate cancer rates and deaths have plummeted worldwid

Prostate cancer and death rates have plummeted worldwide, study reveals About one in nine men develop prostate cancer over the course of their lives  In 1994, a blood test for the cancer was approved by the FDA  But the test led to over-diagnosis and has fallen out of favor  In 44 countries, prostate cancer rates

Darolutamide Slows Spread of Castration-Resistant Prostate Cancer

TUESDAY, Feb. 19, 2019 — Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide versus placebo, according to a phase 3 study published online Feb. 14 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb.

These four complaints indicate prostate cancer

What are the symptoms that indicate a change in the prostate? Prostate cancer is the most common cancer in men. Every year, around 60,000 new cases occur. According to information of the German cancer society every fourth Tumor in men develops in the prostate. Approximately 10 percent of the cases end fatally. Thus, the prostate

Electrical activity in prostate cancer cells

Experts from the Universities of Bath and Seville have carried out a series of experiments by which, for the first time, they have characterized the normal electrical activity in PC-3 prostate cancer cells in real time, with a resulting low-frequency electrical pattern between 0.1 and 10 Hertz. “We have observed that this electrical activity evolves

YouTube fueling prostate myths: 77% of top 150 videos contain errors

YouTube fueling prostate myths: 77% of 150 most watched videos ‘have factual errors’ There are well over half a million videos about prostate cancer on YouTube  More than 77 percent of the videos included incorrect or biased information about the disease About half of the videos did not describe the recommended ‘shared decision-making’ doctors and

Early PSA testing could help predict prostate cancer among black men

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It’s more common—and more than twice as deadly—among black men compared to their white counterparts. Yet the United States Preventive Services Task Force (USPSTF) recommendations for prostate cancer screening do not differentiate for race,

Guideline-discordant prostate cancer imaging up with Medicare

(HealthDay)—Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging, according to a study published online Aug. 17 in JAMA Network Open. Danil V. Makarov, M.D., from New York University School of Medicine in New York City, and colleagues examined the correlation between prostate cancer imaging rates and